FDA.reportPublic FDA data

dapsone 7.5 % Topical Gel

RxCUI
1741905
RxNorm name
dapsone 7.5 % Topical Gel
Display name
dapsone 7.5 % Topical Gel
Full name
dapsone 7.5 % Topical Gel
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:53

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 12 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
AczoneDAPSONEAlmirall, LLC22058b7d-a578-4eaa-a476-ac982337f02a2025-10-23Warnings, Adverse reactionsExact identifier
rxcui: 1741905
DapsoneDAPSONEAlembic Pharmaceuticals Limitedd71eba65-3d78-4252-acb8-90eea60921d12025-09-25Warnings, Adverse reactionsExact identifier
rxcui: 1741905
DapsoneDAPSONETrupharma, LLC2763bcbb-e249-be2b-e063-6394a90a50152025-09-05Warnings, Adverse reactionsExact identifier
rxcui: 1741905
DapsoneDAPSONENORTHSTAR RX LLC51ebcb4d-4368-4748-a6f3-1ec2100fed632025-07-09Warnings, Adverse reactionsExact identifier
rxcui: 1741905
DapsoneDAPSONESun Pharmaceutical Industries, Inc.32fcb7e0-5a6d-4d95-b81c-148012a541122025-07-02Warnings, Adverse reactionsExact identifier
rxcui: 1741905
DapsoneDAPSONEMayne Pharma Commercial LLCcbf9e81e-00ef-4218-975e-6a1610b7f1dd2025-06-09Warnings, Adverse reactionsExact identifier
rxcui: 1741905
dapsoneDAPSONETorrent Pharmaceuticals Limitedf8cffc24-8310-4f21-ae77-7f6ad60955512025-06-05Warnings, Adverse reactionsExact identifier
rxcui: 1741905
DapsoneDAPSONEAlembic Pharmaceuticals Inc.2811f7de-13bf-45cd-8413-5b04d11f40ff2025-04-03Warnings, Adverse reactionsExact identifier
rxcui: 1741905
DapsoneDAPSONEMylan Pharmaceuticals Inc.e04da0a1-d02a-487d-a931-a31034738fdd2024-05-31Warnings, Adverse reactionsExact identifier
rxcui: 1741905
DapsoneDAPSONEViona Pharmaceuticals Inc30867c69-cf3c-4360-8e56-db96e0b0c3ab2024-05-11Warnings, Adverse reactionsExact identifier
rxcui: 1741905
DapsoneDAPSONEZydus Lifesciences Limited8b63b653-0507-4f95-9bfa-70fd071e15a62024-05-09Exact identifier
rxcui: 1741905
DapsoneDASPONEAmneal Pharmaceuticals NY LLCfba0b181-077a-4667-bde1-cf9592f120c22023-05-31Warnings, Adverse reactionsExact identifier
rxcui: 1741905

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 14 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
32fcb7e0-5a6d-4d95-b81c-148012a54112dapsone 7.5 % Topical Gel [PSN] · dapsone 0.075 MG/MG Topical Gel [SCD] · dapsone 7.5 % Topical Gel [SY]39These highlights do not include all the information needed to use DAPSONE GEL safely and effectively. See full prescribing information for DAPSONE GEL. DAPSONE gel, for topical use Initial U.S. Approval: 195520250702
22058b7d-a578-4eaa-a476-ac982337f02adapsone 7.5 % Topical Gel [PSN] · dapsone 0.075 MG/MG Topical Gel [SCD] · dapsone 7.5 % Topical Gel [SY]37These highlights do not include all the information needed to use ACZONE ® Gel, 7.5% safely and effectively. See full prescribing information for ACZONE ® Gel, 7.5%. ACZONE ® (dapsone) Gel, 7.5%, for topical use Initial U.S. Approval: 195520251023
f8cffc24-8310-4f21-ae77-7f6ad6095551dapsone 7.5 % Topical Gel [PSN] · dapsone 0.075 MG/MG Topical Gel [SCD] · dapsone 7.5 % Topical Gel [SY]37These highlights do not include all the information needed to use DAPSONE GEL safely and effectively. See full prescribing information for DAPSONE GEL. DAPSONE gel, for topical use Initial U.S. Approval: 195520250605
fba0b181-077a-4667-bde1-cf9592f120c2dapsone 7.5 % Topical Gel [PSN] · dapsone 0.075 MG/MG Topical Gel [SCD] · dapsone 7.5 % Topical Gel [SY]37These highlights do not include all the information needed to use DAPSONE GEL safely and effectively. See full prescribing information for DAPSONE GEL. DAPSONE gel, for topical use Initial U.S. Approval: 195520230531
2811f7de-13bf-45cd-8413-5b04d11f40ffdapsone 7.5 % Topical Gel [PSN] · dapsone 0.075 MG/MG Topical Gel [SCD] · dapsone 7.5 % Topical Gel [SY]36These highlights do not include all the information needed to use DAPSONE GEL safely and effectively. See full prescribing information for DAPSONE GEL. DAPSONE Gel, for topical use Initial U.S. Approval: 195520250403
cbf9e81e-00ef-4218-975e-6a1610b7f1dddapsone 7.5 % Topical Gel [PSN] · dapsone 0.075 MG/MG Topical Gel [SCD] · dapsone 7.5 % Topical Gel [SY]35These highlights do not include all the information needed to use DAPSONE GEL safely and effectively. See full prescribing information for DAPSONE GEL. DAPSONE gel, for topical use Initial U.S. Approval: 195520250609
2763bcbb-e249-be2b-e063-6394a90a5015dapsone 7.5 % Topical Gel [PSN] · dapsone 0.075 MG/MG Topical Gel [SCD] · dapsone 7.5 % Topical Gel [SY]33These highlights do not include all the information needed to use DAPSONE GEL safely and effectively. See full prescribing information for DAPSONE GEL. DAPSONE gel, for topical use Initial U.S. Approval: 195520250905
ec99b115-d163-4145-8c76-cb1a008305a4dapsone 7.5 % Topical Gel [PSN] · dapsone 0.075 MG/MG Topical Gel [SCD] · dapsone 7.5 % Topical Gel [SY]33These highlights do not include all the information needed to use Dapsone Gel, 7.5% safely and effectively. See full prescribing information for Dapsone Gel, 7.5%. Dapsone Gel, 7.5%, for topical use Initial U.S. Approval: 195520210505
51ebcb4d-4368-4748-a6f3-1ec2100fed63dapsone 7.5 % Topical Gel [PSN] · dapsone 0.075 MG/MG Topical Gel [SCD] · dapsone 7.5 % Topical Gel [SY]32These highlights do not include all the information needed to use DAPSONE GEL safely and effectively. See full prescribing information for DAPSONE GEL. DAPSONE gel, for topical use Initial U.S. Approval: 195520250709
e04da0a1-d02a-487d-a931-a31034738fdddapsone 7.5 % Topical Gel [PSN] · dapsone 0.075 MG/MG Topical Gel [SCD] · dapsone 7.5 % Topical Gel [SY]32These highlights do not include all the information needed to use DAPSONE GEL safely and effectively. See full prescribing information for DAPSONE GEL . DAPSONE gel, for topical use Initial U.S. Approval: 195520240531
30867c69-cf3c-4360-8e56-db96e0b0c3abdapsone 7.5 % Topical Gel [PSN] · dapsone 0.075 MG/MG Topical Gel [SCD] · dapsone 7.5 % Topical Gel [SY]32These highlights do not include all the information needed to use DAPSONE GEL safely and effectively. See full prescribing information for DAPSONE GEL. DAPSONE gel, for topical use Initial U.S. Approval: 195520240511
d71eba65-3d78-4252-acb8-90eea60921d1dapsone 7.5 % Topical Gel [PSN] · dapsone 0.075 MG/MG Topical Gel [SCD] · dapsone 7.5 % Topical Gel [SY]31These highlights do not include all the information needed to use DAPSONE GEL safely and effectively. See full prescribing information for DAPSONE GEL. DAPSONE Gel, for topical use Initial U.S. Approval: 195520250925
2151f538-0a68-4d71-e063-6294a90ad085dapsone 7.5 % Topical Gel [PSN] · dapsone 0.075 MG/MG Topical Gel [SCD] · dapsone 7.5 % Topical Gel [SY]31These highlights do not include all the information needed to use DAPSONE GEL safely and effectively. See full prescribing information for DAPSONE GEL. DAPSONE gel, for topical use Initial U.S. Approval: 195520240904
8b63b653-0507-4f95-9bfa-70fd071e15a6dapsone 7.5 % Topical Gel [PSN] · dapsone 0.075 MG/MG Topical Gel [SCD] · dapsone 7.5 % Topical Gel [SY]31Dapsone Gel20240509